over $1b revenue and more than 40% margin, page-23

If this deal is substantial and as suspected over a long period and with one of the big pharmas it will be as much about credibility and validation of the company as dollars. The company has given guidence there are possibly 10 more deals that will be done by years end , this deal being signed will only add substancial credibilty to that and I think the re rate from this pending deal and for the remainder of the year will be spectacular.

The rise of the sp and trading in the last few sessions has been impressive but is only the tip of the iceberg ATM .there is a mile of upside on the Nasdaq once the shorts get busted arse and masses go long and hard.
That might just start tonight